应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NAVB Navidea生物制药
盘前交易 03-27 16:00:00 EDT 延时
资讯
新帖
简况
美国OTC市场Navidea Biopharmaceuticals, Inc.股价飙升12.50% 市值涨1.13万美元
市场透视 · 02-25
美国OTC市场Navidea Biopharmaceuticals, Inc.股价飙升12.50% 市值涨1.13万美元
美国OTC市场Navidea Biopharmaceuticals, Inc.股价拉升14.29% 市值涨1.14万美元
市场透视 · 02-19
美国OTC市场Navidea Biopharmaceuticals, Inc.股价拉升14.29% 市值涨1.14万美元
美国OTC市场Navidea Biopharmaceuticals, Inc.股价飙升16.67% 市值涨1.17万美元
市场透视 · 02-13
美国OTC市场Navidea Biopharmaceuticals, Inc.股价飙升16.67% 市值涨1.17万美元
美国OTC市场Navidea Biopharmaceuticals, Inc.盘中异动 股价大涨100.00%报0.001美元
市场透视 · 2024-11-08
美国OTC市场Navidea Biopharmaceuticals, Inc.盘中异动 股价大涨100.00%报0.001美元
美国OTC市场Navidea Biopharmaceuticals, Inc.股价重挫60.00% 市值跌1.2万美元
市场透视 · 2024-11-05
美国OTC市场Navidea Biopharmaceuticals, Inc.股价重挫60.00% 市值跌1.2万美元
美国OTC市场Navidea Biopharmaceuticals, Inc.股价重挫50.00% 市值跌2.5万美元
市场透视 · 2024-11-04
美国OTC市场Navidea Biopharmaceuticals, Inc.股价重挫50.00% 市值跌2.5万美元
美国OTC市场Navidea Biopharmaceuticals, Inc.盘中异动 下午盘股价大涨40.00%报0.001美元
市场透视 · 2024-09-25
美国OTC市场Navidea Biopharmaceuticals, Inc.盘中异动 下午盘股价大涨40.00%报0.001美元
加载更多
公司概况
公司名称:
Navidea生物制药
所属市场:
EXPERT
上市日期:
--
主营业务:
Navidea Biopharmaceuticals, Inc.最初于1983年在俄亥俄州成立,并于1988年重新合并在特拉州。Navidea生物制药有限公司是一家生物制药公司,专注于创新精密的诊断试剂的开发和商业化,旨在提高诊断的准确性,临床决策和病人护理。
发行价格:
--
{"stockData":{"symbol":"NAVB","market":"US","secType":"STK","nameCN":"Navidea生物制药","latestPrice":0.0004,"timestamp":1743105600000,"preClose":0.0004,"halted":0,"volume":2000,"delay":15,"floatShares":64072382,"shares":99994385,"eps":-0.026045,"marketStatus":"盘前交易","change":0,"latestTime":"03-27 16:00:00 EDT 延时","open":0.0004,"high":0.0004,"low":0.0004,"amount":0.8,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.026045,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1743168600000},"marketStatusCode":1,"adr":0,"exchange":"EXPERT","adjPreClose":0.0004,"volumeRatio":0.7321180576241704},"requestUrl":"/m/hq/s/NAVB","defaultTab":"news","newsList":[{"id":"2514117450","title":"美国OTC市场Navidea Biopharmaceuticals, Inc.股价飙升12.50% 市值涨1.13万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514117450","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514117450?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:41","pubTimestamp":1740501661,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时41分,美国OTC市场Navidea Biopharmaceuticals, Inc.股票出现波动,股价快速上涨12.50%。美国OTC市场Navidea Biopharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.02%。其相关个股中,Abpro Holdings Inc C/Wts 12/11/2029 、Silexion Therapeutics Corp、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Gt Biopharma, Inc.、Silexion Therapeutics Corp、Moleculin Biotech, Inc.较为活跃,换手率分别为1118.05%、926.01%、695.16%,振幅较大的相关个股有Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 、Adial Pharmaceuticals, Inc,振幅分别为87.83%、66.67%、64.05%。美国OTC市场Navidea Biopharmaceuticals, Inc.公司简介:Navidea Biopharmaceuticals Inc是一家专注于精准医学的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226004101a253a42f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226004101a253a42f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAVB","BK4139"],"gpt_icon":0},{"id":"2512433952","title":"美国OTC市场Navidea Biopharmaceuticals, Inc.股价拉升14.29% 市值涨1.14万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512433952","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512433952?lang=zh_cn&edition=full","pubTime":"2025-02-20 02:28","pubTimestamp":1739989681,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日02时28分,美国OTC市场Navidea Biopharmaceuticals, Inc.股票出现异动,股价急速拉升14.29%。美国OTC市场Navidea Biopharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.45%。其相关个股中,Osr Holdings, Inc.、Osr Holdings Inc C/Wts 02/09/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大,Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃,换手率分别为661.25%、253.38%、223.09%,振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Osr Holdings, Inc.、Immatics N V C/Wts 01/07/2025 ,振幅分别为264.94%、159.49%、58.67%。美国OTC市场Navidea Biopharmaceuticals, Inc.公司简介:Navidea Biopharmaceuticals Inc是一家专注于精准医学的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220022801a24c2555&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220022801a24c2555&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NAVB"],"gpt_icon":0},{"id":"2511742485","title":"美国OTC市场Navidea Biopharmaceuticals, Inc.股价飙升16.67% 市值涨1.17万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511742485","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511742485?lang=zh_cn&edition=full","pubTime":"2025-02-14 03:50","pubTimestamp":1739476201,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日03时50分,美国OTC市场Navidea Biopharmaceuticals, Inc.股票出现波动,股价快速拉升16.67%。美国OTC市场Navidea Biopharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.11%。其相关个股中,Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Dominari Holdings Inc.涨幅较大,Edesa Biotech, Inc.、Moleculin Biotech, Inc.、Tc Biopharm Plc较为活跃,换手率分别为3226.11%、2098.34%、1244.09%,振幅较大的相关个股有Moleculin Biotech, Inc.、Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 ,振幅分别为733.31%、95.15%、92.30%。美国OTC市场Navidea Biopharmaceuticals, Inc.公司简介:Navidea Biopharmaceuticals Inc是一家专注于精准医学的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214035001abcdf062&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214035001abcdf062&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NAVB"],"gpt_icon":0},{"id":"2481488293","title":"美国OTC市场Navidea Biopharmaceuticals, Inc.盘中异动 股价大涨100.00%报0.001美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481488293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2481488293?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:44","pubTimestamp":1731080664,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日23时44分,美国OTC市场Navidea Biopharmaceuticals, Inc.股票出现波动,股价急速拉升100.00%。截至发稿,该股报0.001美元/股,成交量1235股,换手率0.00%,振幅0.00%。美国OTC市场Navidea Biopharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.99%。美国OTC市场Navidea Biopharmaceuticals, Inc.公司简介:Navidea Biopharmaceuticals Inc是一家专注于精准医学的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110823442498e41855&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110823442498e41855&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAVB","BK4139"],"gpt_icon":0},{"id":"2481824696","title":"美国OTC市场Navidea Biopharmaceuticals, Inc.股价重挫60.00% 市值跌1.2万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481824696","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2481824696?lang=zh_cn&edition=full","pubTime":"2024-11-06 00:23","pubTimestamp":1730823781,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日00时23分,美国OTC市场Navidea Biopharmaceuticals, Inc.股票出现波动,股价大幅下跌60.00%。美国OTC市场Navidea Biopharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.95%。美国OTC市场Navidea Biopharmaceuticals, Inc.公司简介:Navidea Biopharmaceuticals Inc是一家专注于精准医学的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110600230195bdd33c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110600230195bdd33c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NAVB"],"gpt_icon":0},{"id":"2480840595","title":"美国OTC市场Navidea Biopharmaceuticals, Inc.股价重挫50.00% 市值跌2.5万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480840595","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2480840595?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:48","pubTimestamp":1730731682,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时48分,美国OTC市场Navidea Biopharmaceuticals, Inc.股票出现异动,股价大幅下跌50.00%。美国OTC市场Navidea Biopharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.15%。其相关个股中,Disc Medicine, Inc.、Neurogene Inc.、Tenaya Therapeutics, Inc.涨幅较大,Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃,换手率分别为252.59%、161.73%、53.43%,振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 24/02/2025、Nls Pharmaceutics Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为29.83%、25.56%、22.67%。美国OTC市场Navidea Biopharmaceuticals, Inc.公司简介:Navidea Biopharmaceuticals Inc是一家专注于精准医学的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422480395bdca73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422480395bdca73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAVB","BK4139"],"gpt_icon":0},{"id":"2470129733","title":"美国OTC市场Navidea Biopharmaceuticals, Inc.盘中异动 下午盘股价大涨40.00%报0.001美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470129733","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2470129733?lang=zh_cn&edition=full","pubTime":"2024-09-26 03:12","pubTimestamp":1727291521,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日03时12分,美国OTC市场Navidea Biopharmaceuticals, Inc.股票出现异动,股价快速上涨40.00%。截至发稿,该股报0.001美元/股,成交量3343股,换手率0.00%,振幅40.00%。美国OTC市场Navidea Biopharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.44%。美国OTC市场Navidea Biopharmaceuticals, Inc.公司简介:Navidea Biopharmaceuticals Inc是一家专注于精准医学的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926031201957d8943&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926031201957d8943&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NAVB","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.navidea.com","description":"Navidea Biopharmaceuticals, Inc.最初于1983年在俄亥俄州成立,并于1988年重新合并在特拉州。Navidea生物制药有限公司是一家生物制药公司,专注于创新精密的诊断试剂的开发和商业化,旨在提高诊断的准确性,临床决策和病人护理。","exchange":"EXPERT","name":"Navidea生物制药","nameEN":"Navidea Biopharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Navidea生物制药(NAVB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Navidea生物制药(NAVB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Navidea生物制药,NAVB,Navidea生物制药股票,Navidea生物制药股票老虎,Navidea生物制药股票老虎国际,Navidea生物制药行情,Navidea生物制药股票行情,Navidea生物制药股价,Navidea生物制药股市,Navidea生物制药股票价格,Navidea生物制药股票交易,Navidea生物制药股票购买,Navidea生物制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Navidea生物制药(NAVB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Navidea生物制药(NAVB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}